Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
Titel:
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
Auteur:
Slovin, S.F. Higano, C.S. Hamid, O. Tejwani, S. Harzstark, A. Alumkal, J.J. Scher, H.I. Chin, K. Gagnier, P. McHenry, M.B. Beer, T.M.